Bayer acquires Noria and PSMA Therapeutics to expand portfolio in prostate cancer
The Pharma Data
JUNE 28, 2021
The companies acquired by Bayer, Noria and PSMA Therapeutics, have exclusive world-wide rights to technology licensed from Weill Cornell Medicine (New York, NY, USA) and Johns Hopkins University (Baltimore, MD, USA). Noria was founded by Dr. John Babich, Chief, Radiopharmaceutical Sciences in Radiology at Weill Cornell Medicine.
Let's personalize your content